ventilator associated pneumonia. Ventilator associated pneumonia
Conditions
Interventions
Intervention 1: Intervention group: Patients in this group will receive15 ml of pre-prepared solution containing 0.2% chlorhexidine (Iran Najo Pharmaceutical Company) alone 2 times a day for 5 days. T
Sponsors
Zabol University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: No damage to the mouth, jaw and face Oral health assessment checklist score 10 and less Clinical score of lung infection less than 6 on arrival The patient should be Undergo airway intubation on the first day The patient should remain intubated for at least 72 hours No immunosuppression due to certain drugs or diseases
Exclusion criteria
Exclusion criteria: Malignancy Diabetes Chronic obstructive pulmonary disease History of broad-spectrum antibiotic therapy in the last 3 months Dissatisfaction of patient or his/her companion to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ventilator associated pneumonia. Timepoint: Ventilator associated pneumonia will be determined 5 days after the intervention. Method of measurement: Clinical Pulmonary Infection Score. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMostafa Mirzaei
Zabol University of Medical Sciences
Outcome results
None listed